| Code | Description | Claims | Bene. Records | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
11,395 |
8,916 |
$502K |
| 90833 |
Psychotherapy, 30 minutes with patient when performed with an E&M service (add-on) |
7,317 |
5,563 |
$200K |
| 90837 |
Psychotherapy, 53 minutes with patient |
913 |
694 |
$80K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
1,742 |
1,247 |
$76K |
| Q3014 |
Telehealth originating site facility fee |
4,963 |
3,648 |
$68K |
| 90832 |
Psychotherapy, 30 minutes with patient |
1,176 |
320 |
$49K |
| H0002 |
Behavioral health screening to determine eligibility for admission to treatment program |
1,088 |
971 |
$32K |
| 99308 |
Subsequent nursing facility care, per day, straightforward |
2,822 |
2,109 |
$28K |
| 99309 |
Subsequent nursing facility care, per day, low to moderate complexity |
854 |
578 |
$21K |
| 90791 |
Psychiatric diagnostic evaluation |
165 |
163 |
$19K |
| T1016 |
Case management, each 15 minutes |
200 |
87 |
$16K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
441 |
334 |
$11K |
| 90834 |
Psychotherapy, 45 minutes with patient |
175 |
159 |
$10K |
| 90876 |
|
107 |
85 |
$9K |
| 99205 |
Prolong outpt/office vis |
15 |
14 |
$2K |
| 99215 |
Prolong outpt/office vis |
18 |
14 |
$1K |
| 99306 |
Prolong nursin fac eval 15m |
66 |
66 |
$934.61 |
| 99305 |
|
64 |
64 |
$641.28 |
| G0483 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 22 or more drug class(es), including metabolite(s) if performed |
59 |
46 |
$0.00 |